Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVOS: Patient Preference for Oral or Intravenous Vinorelbine in Advanced NSCLC
NCT01848613Phase 4Completed
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Oct 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Started Oct 2012; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01848613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848613.